The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price decrease of -5.99%. However, over the past six months, we’ve seen a weaker performance of 64.93%. The price of GOSS fallen by 11.40% over the last 30 days. And in the last five days, it has surged by 11.91%.
Gossamer Bio Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $1.60 on 03/07/24, while the lowest price for the same period was registered at $0.50 on 06/10/24.
52-week price history of GOSS Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Gossamer Bio Inc’s current trading price is -46.39% away from its 52-week high, while its distance from the 52-week low is 71.80%. The stock’s price range during this time has been between $0.50 and $1.60. The trading volume for the Healthcare sector company’s shares reached about 2.47 million for the day, which was higher than the average daily volume of 1.29 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Gossamer Bio Inc (GOSS) has experienced a quarterly decline of -4.55% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 198.65M and boasts a workforce of 135 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.8802, with a change in price of -0.2322. Similarly, Gossamer Bio Inc recorded 1,179,933 in trading volume during the last 100 days, posting a change of -21.30%.
GOSS’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for GOSS stands at 3.76. Similarly, the long-term debt-to-equity ratio is also 3.73.
GOSS Stock Stochastic Average
Today’s raw stochastic average for Gossamer Bio Inc over the last 50 days is 44.74%.This indicates a increase from the raw stochastic average of the past 20 days, which was 44.74%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 54.20% and 46.60%, respectively.
